ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Estrella Immunopharma Inc

Estrella Immunopharma Inc (ESLA)

1.17
0.00
(0.00%)
Closed December 27 4:00PM
1.20
0.03
(2.56%)
After Hours: 7:59PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
1.17
Bid
1.15
Ask
1.29
Volume
28,778
1.06 Day's Range 1.29
0.63 52 Week Range 3.23
Market Cap
Previous Close
1.17
Open
1.24
Last Trade
138
@
1.17
Last Trade Time
Financial Volume
$ 35,598
VWAP
1.237
Average Volume (3m)
39,509
Shares Outstanding
36,179,147
Dividend Yield
-
PE Ratio
-5.94
Earnings Per Share (EPS)
-0.2
Revenue
-
Net Profit
-7.31M

About Estrella Immunopharma Inc

TradeUP Acquisition Corp is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. TradeUP Acquisition Corp is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Wilmington, Delaware, USA
Founded
-
Estrella Immunopharma Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ESLA. The last closing price for Estrella Immunopharma was $1.17. Over the last year, Estrella Immunopharma shares have traded in a share price range of $ 0.63 to $ 3.23.

Estrella Immunopharma currently has 36,179,147 shares outstanding. The market capitalization of Estrella Immunopharma is $42.33 million. Estrella Immunopharma has a price to earnings ratio (PE ratio) of -5.94.

ESLA Latest News

Estrella Immunopharma Achieves Complete Response in First Patient Treated with CD19- Redirected ARTEMIS® T-cells

Estrella Immunopharma, Inc. (NASDAQ: ESLA, ESLAW) (“Estrella” or the “Company”), a clinical stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to treat...

Estrella Immunopharma Announces Appointment of Hong Zhang as Chairperson and Board Member

Estrella Immunopharma, Inc. (NASDAQ: ESLA, ESLAW) ("Estrella", “Estrella Immunopharma”, or the "Company"), a clinical stage biopharmaceutical company focused on developing CD19 and CD22-targeted...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.02-1.680672268911.191.291.02141651.13850648CS
40.065.405405405411.111.4851.02603381.28553591CS
12-0.03-2.51.21.4850.63395091.07657405CS
260.2425.80645161290.933.230.631173901.47738608CS
520.010.8620689655171.163.230.63738981.4053221CS
156-4.04-77.54318618045.215.620.63773341.55863201CS
260-4.04-77.54318618045.215.620.63773341.55863201CS

ESLA - Frequently Asked Questions (FAQ)

What is the current Estrella Immunopharma share price?
The current share price of Estrella Immunopharma is $ 1.17
How many Estrella Immunopharma shares are in issue?
Estrella Immunopharma has 36,179,147 shares in issue
What is the market cap of Estrella Immunopharma?
The market capitalisation of Estrella Immunopharma is USD 42.33M
What is the 1 year trading range for Estrella Immunopharma share price?
Estrella Immunopharma has traded in the range of $ 0.63 to $ 3.23 during the past year
What is the PE ratio of Estrella Immunopharma?
The price to earnings ratio of Estrella Immunopharma is -5.94
What is the reporting currency for Estrella Immunopharma?
Estrella Immunopharma reports financial results in USD
What is the latest annual profit for Estrella Immunopharma?
The latest annual profit of Estrella Immunopharma is USD -7.31M
What is the registered address of Estrella Immunopharma?
The registered address for Estrella Immunopharma is 108 W. 13TH STREET, SUITE 100, WILMINGTON, DELAWARE, 19801
Which industry sector does Estrella Immunopharma operate in?
Estrella Immunopharma operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AIREreAlpha Tech Corporation
$ 3.5701
(160.59%)
130.88M
SPRCSciSparc Ltd
$ 0.50
(126.04%)
239.51M
ZCARZoomcar Holdings Inc
$ 2.80
(95.80%)
60.3M
MGIHMillennium Group International Holdings Ltd
$ 2.9698
(94.10%)
75.35M
SKKSKK Holdings Limited
$ 1.35
(80.48%)
52.11M
LNKSLinkers Industries Ltd
$ 3.295
(-65.64%)
3.65M
GTIGraphjet Technology
$ 0.3354
(-45.02%)
22.44M
BAOSBaosheng Media Group Holdings Ltd
$ 4.3979
(-38.06%)
1.97M
NEUPNeuphoria Therapeutics Inc
$ 4.34
(-34.54%)
599.97k
SVRESaverOne 2014 Ltd
$ 1.0501
(-30.46%)
1.36M
XTIAXTI Aerospace Inc
$ 0.0398
(1.53%)
270.76M
SPRCSciSparc Ltd
$ 0.50
(126.04%)
239.51M
COEPCoeptis Therapeutics Holdings Inc
$ 0.213249
(50.18%)
205.2M
RGTIRigetti Computing Inc
$ 15.445
(36.08%)
204.3M
SMXSMX Security Matters Public Company
$ 0.3303
(51.51%)
172.17M